Clinical Trial Update: The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma

View source ↗

Summary

A clinical trial update describes the risk of exacerbation of chronic hepatitis B after percutaneous radiofrequency ablation of hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatocellular Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatitis B, Hepatocellular Carcinoma | Status: UNKNOWN